Back to Search
Start Over
Intravitreal Aflibercept as a Rescue Therapy for Retinal Neovascularization and Macular Edema due to Eales Disease.
- Source :
-
Case Reports in Ophthalmological Medicine . 2/11/2021, p1-5. 5p. - Publication Year :
- 2021
-
Abstract
- We report the rescue effect of intravitreal aflibercept injections on retinal neovascularization and macular edema due to Eales disease. Case 1 was a 36-year-old female. Intravitreal aflibercept was administered as rescue therapy after persistent retinal neovascularization following retinal photocoagulation, periocular triamcinolone, and intravitreal ranibizumab injection. Retinal neovascularization initially regressed, but recurred after 5 months along with macular edema. Two more intravitreal aflibercept injections were given, and retinal neovascularization with macular edema regressed. Her vision improved to 20/25 and remained stable after 43 months. Case 2 was a 27-year-old female. Intravitreal aflibercept was administered after persistent retinal neovascularization and macular edema following periocular triamcinolone injection. The macular edema initially subsided but recurred after 3 months. Intravitreal aflibercept injections were then administered once every three months to maintain her vision 20/20. The patient has been followed up for 28 months. Intravitreal aflibercept was effective as a rescue therapy in the treatment of Eales disease to regress retinal neovascularization, though repeated injections were necessary in cases of recurrence. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 20906722
- Database :
- Academic Search Index
- Journal :
- Case Reports in Ophthalmological Medicine
- Publication Type :
- Academic Journal
- Accession number :
- 148654086
- Full Text :
- https://doi.org/10.1155/2021/8887362